Phospho-TP53 (S378) Antibody

What is the Phospho-TP53 (S378) Antibody and what epitope does it recognize?

The Phospho-TP53 (S378) Antibody is a rabbit polyclonal antibody that specifically recognizes the TP53 protein (p53) only when phosphorylated at Serine 378. This antibody detects endogenous levels of p53 protein specifically in its phosphorylated state at position S378. The antibody is generated using a synthesized peptide derived from human p53 around the phosphorylation site of Ser378, typically covering the amino acid range 344-393 . The specificity for the phosphorylated form makes this antibody valuable for studying post-translational modifications of p53 in various cellular conditions.

What applications is the Phospho-TP53 (S378) Antibody validated for?

The Phospho-TP53 (S378) Antibody has been validated for several research applications:

• Western Blotting (WB): Typically used at dilutions of 1:500-1:2000

• Enzyme-Linked Immunosorbent Assay (ELISA): Recommended at dilutions of approximately 1:20000

• Some versions may also be suitable for immunohistochemistry applications, although this varies by manufacturer

When using this antibody for Western blot applications, researchers should verify band specificity by using appropriate controls, including phosphopeptide competition assays, as demonstrated in validation studies where the detection band is blocked with the phospho-peptide .

What are the recommended storage and handling conditions?

For optimal antibody performance and longevity:

• Store at -20°C for long-term storage (up to 1 year from date of receipt)

• For frequent use and short-term storage, the antibody can be kept at 4°C for up to one month

• Avoid repeated freeze-thaw cycles as they can degrade the antibody and affect performance

• The antibody is typically formulated in liquid PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide, which helps maintain stability

What species reactivity does the Phospho-TP53 (S378) Antibody exhibit?

The Phospho-TP53 (S378) Antibody exhibits cross-reactivity with:

• Human p53

• Mouse p53

• Rat p53

Some manufacturers may predict reactivity with additional species such as pig, bovine, sheep, and rabbit based on sequence homology, though these may require validation in the specific research context.

How does phosphorylation at S378 affect p53's interaction with 14-3-3 proteins?

Phosphorylation of p53 at S378 creates a binding site for 14-3-3 proteins, though with interesting nuances:

• Multiple phosphorylation sites, including S366, S378, and T387, contribute to 14-3-3 binding

• Different 14-3-3 isoforms (γ, ε, τ, and σ) interact with p53 with varying affinities and potentially through different binding sites

• While direct binding to pS378 occurs, systematic mutational studies suggest that S378 phosphorylation may not be absolutely essential for all 14-3-3 isoform interactions

• In vitro and in vivo results indicate that 14-3-3 γ and ε interact with p53 phosphorylated at S366, S378, and T387, while 14-3-3 τ and σ isoforms may have additional binding sites

Fluorescence binding measurements on p53 CTD phosphopeptides confirm that different 14-3-3 isoforms bind p53 CTD with varying affinities, suggesting isoform-specific regulation mechanisms .

What is the relationship between DNA damage and p53 S378 phosphorylation?

DNA damage induces complex phosphorylation patterns of p53, including at S378:

• Upon DNA damage (e.g., after treatment with camptothecin or other topoisomerase inhibitors), the Chk1/Chk2 kinases phosphorylate p53 at multiple sites including S366, S378, and T387

• This phosphorylation is part of the ATM and Chk1/Chk2 pathway activation following double-stranded DNA breaks

• Phosphorylation at S378 appears to be part of a regulatory mechanism that modulates p53's transcriptional activity and stability through altered protein-protein interactions

• Interestingly, under some conditions, S376 may be dephosphorylated upon DNA damage, creating a 14-3-3 consensus binding site in conjunction with phosphorylated S378

The dynamic phosphorylation and dephosphorylation events at these sites highlight the complex post-translational regulation of p53 function.

How can I verify the specificity of Phospho-TP53 (S378) Antibody in my experimental setup?

Proper validation of phospho-specific antibodies is critical. Recommended approaches include:

• Phosphopeptide competition assay: Pre-incubate the antibody with the phosphorylated peptide used as an immunogen and observe the abolishment of signal in Western blot or immunostaining

• Mutational studies: Compare antibody reactivity between wild-type and S378A mutant p53 expressed in p53-null cell lines (e.g., H1299)

• Validation across multiple applications: Test specificity in both Western blot and ELISA formats

• Phosphatase treatment: Treat samples with lambda phosphatase to remove phosphorylation and observe loss of signal

• Stimulus-dependent detection: Verify increased signal following DNA damage induction (e.g., with camptothecin treatment) compared to control conditions

For example, validation studies using enzyme-linked immunosorbent assays (Phospho-ELISA) comparing signal between phosphopeptide and non-phosphopeptide can demonstrate specificity, as can Western blot analysis of lysates from treated cells (e.g., UV treatment) with and without phosphopeptide blocking .

What kinases are responsible for phosphorylating p53 at S378?

The phosphorylation of p53 at S378 is regulated by specific kinases in response to cellular stresses:

• Chk1 and Chk2 kinases have been identified as responsible for phosphorylating p53 at S378 following DNA damage

• These kinases are activated downstream of ATM and ATR kinases in the DNA damage response pathway

• The phosphorylation occurs as part of a coordinated response that includes modification at multiple sites

• Under normal conditions, some basal phosphorylation at S378 may occur, but this is significantly enhanced following DNA damage or other cellular stresses

Understanding the kinase-specificity helps in designing experiments to modulate this phosphorylation through specific kinase inhibitors or activators.

How does S378 phosphorylation compare to other p53 phosphorylation sites?

p53 contains numerous phosphorylation sites with distinct functions:

Unlike S15 and S20 phosphorylation, which primarily affect MDM2 binding and p53 stability, S378 phosphorylation appears to be more involved in modulating protein-protein interactions, particularly with 14-3-3 proteins, potentially affecting downstream transcriptional activity .

What is the functional significance of 14-3-3 protein binding to phosphorylated p53 at S378?

The interaction between 14-3-3 proteins and phosphorylated p53 has several functional consequences:

• All four studied 14-3-3 isoforms (γ, ε, τ, and σ) enhance the transcriptional activity of p53

• 14-3-3 τ and σ increase p53 levels in cells by stabilizing the protein

• 14-3-3 ε and γ activate p53 for sequence-specific DNA binding by stabilizing tetramer formation

• The existence of multiple binding sites for 14-3-3 proteins on p53 may act as a fail-safe mechanism where failure to phosphorylate one residue can be compensated by phosphorylation at other sites

• Similar to how multiple phosphorylations in the p53 transactivation domain stabilize p53 and prevent MDM2-mediated degradation

These interactions represent an important regulatory mechanism for fine-tuning p53 function in response to cellular stresses.

How can I design experiments to investigate the functional consequences of S378 phosphorylation?

To study the specific role of S378 phosphorylation:

• Site-directed mutagenesis: Generate p53 S378A (phospho-deficient) and S378D/E (phospho-mimetic) mutants

• Rescue experiments: Express these mutants in p53-null cell lines (H1299) to assess functional differences

• Transcriptional assays: Use luciferase reporter assays with p53-responsive promoters to measure transcriptional activity differences

• Protein-protein interaction studies:

  • Co-immunoprecipitation with 14-3-3 proteins

  • Pull-down assays with GST-tagged 14-3-3 isoforms

  • Fluorescence binding measurements using phosphopeptides

• Cellular localization: Immunofluorescence studies to assess nuclear vs. cytoplasmic distribution

• Stress response assays: Compare mutant vs. wild-type p53 function following DNA damage, such as:

  • Cell cycle arrest (flow cytometry)

  • Apoptosis induction (Annexin V staining)

  • Target gene expression (RT-qPCR)

What are the most common causes of non-specific signals when using Phospho-TP53 (S378) Antibody?

When working with phospho-specific antibodies, several factors can contribute to non-specific signals:

• Insufficient blocking: Ensure adequate blocking with 5% non-fat milk or BSA in TBST

• Cross-reactivity with similar phospho-epitopes: Many proteins contain similar phosphorylation motifs; verify specificity with knockout/knockdown controls

• Degraded phospho-epitopes: Phosphatases in samples may dephosphorylate the target; use phosphatase inhibitors in all buffers

• Antibody concentration: Titrate the antibody concentration; using too high concentrations can increase background

• Sample preparation issues: Ensure rapid and proper sample preparation to preserve phosphorylation status

• Membrane overexposure: Optimize exposure times in Western blot to avoid detection of weak cross-reactive bands

For optimal results, follow the manufacturer's recommended dilution ranges (typically 1:500-1:2000 for Western blot and 1:20000 for ELISA) .

How can I detect low-abundance phosphorylated p53 in my samples?

Detecting low levels of phosphorylated p53 can be challenging. Consider these approaches:

• Enrichment strategies:

  • Immunoprecipitate total p53 first, then blot with phospho-specific antibody

  • Use phospho-protein enrichment columns prior to Western blot

• Signal amplification methods:

  • Use enhanced chemiluminescence (ECL) substrates with higher sensitivity

  • Consider fluorescently-labeled secondary antibodies with digital imaging

• Increase protein loading: Load more total protein if possible

• Induce phosphorylation: Treat cells with DNA-damaging agents (e.g., camptothecin, UV) to increase phosphorylation levels

• Optimize transfer conditions: Use PVDF membranes and optimize transfer time for high molecular weight proteins

• Reduce background: Use fresh antibody dilutions and highly purified blocking reagents

• Check for phosphatase activity: Ensure phosphatase inhibitors are active in your buffers

How should I interpret Western blot results showing multiple bands when using Phospho-TP53 (S378) Antibody?

Multiple bands in Western blots using phospho-specific antibodies require careful interpretation:

• Expected molecular weight: The main p53 band should appear at approximately 53 kDa

• p53 isoforms: Human p53 has multiple isoforms that may appear as distinct bands

• Post-translational modifications: Additional modifications (ubiquitination, SUMOylation, etc.) can alter migration patterns

• Degradation products: Proteolytic fragments of p53 that retain the phospho-epitope

• Cross-reactivity: Possible detection of other proteins with similar phospho-epitopes

• Verification approaches:

  • Use p53-null cell lines as negative controls

  • Compare with total p53 antibody pattern

  • Perform phosphopeptide competition

  • Use siRNA knockdown to confirm specificity of the main band

The calculated molecular weight of p53 is approximately 43.7 kDa, but it typically runs at around 53 kDa on SDS-PAGE due to its structural properties .

What are the most informative experimental controls when working with Phospho-TP53 (S378) Antibody?

Rigorous controls are essential for phospho-specific antibody experiments:

• Positive controls:

  • Cell lines treated with DNA damaging agents (UV, camptothecin) to induce phosphorylation

  • Recombinant phosphorylated peptides (when available)

• Negative controls:

  • p53-null cell lines (e.g., H1299)

  • Samples treated with lambda phosphatase

  • S378A mutant-expressing cells

• Specificity controls:

  • Phosphopeptide competition assays

  • Comparison with total p53 antibody staining

• Technical controls:

  • Loading controls (e.g., β-actin, GAPDH)

  • Secondary antibody-only controls

  • Untreated vs. treated samples

Proper implementation of these controls will significantly increase confidence in the specificity and reliability of results.

How do interactions between multiple phosphorylation sites on p53 influence experimental design?

p53 regulation involves complex interplay between multiple phosphorylation sites:

• Combinatorial effects: Phosphorylation at S378 may function differently depending on the phosphorylation status of other sites

• Experimental approaches:

  • Generate multi-site mutants (S366A/S378A, S378A/T387A, etc.)

  • Use phospho-specific antibodies against multiple sites on the same samples

  • Perform sequential immunoprecipitation experiments

• Kinase inhibitor studies: Use specific inhibitors to block particular phosphorylation events

• Temporal considerations: Different sites may be phosphorylated with distinct kinetics

• Mass spectrometry analysis: To comprehensively map all modifications present

Research has shown that multiple phosphorylation sites in the p53 C-terminal domain can create redundancy in 14-3-3 binding, possibly acting as a fail-safe mechanism where phosphorylation at one site can compensate for lack of phosphorylation at another .

This comprehensive understanding of site interactions will help design more informative experiments to dissect the specific role of S378 phosphorylation.